跳至主要内容
临床试验/NCT07538700
NCT07538700招募中不适用

Hip-allograft In Proximal Humerus Fractures Versus Plate Implantation Alone: a Randomized Controlled Trial

Tergooi Medical Center1 个研究点 分布在 1 个国家目标入组 56 人开始时间: 2025年5月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
56
试验地点
1
主要终点
Constant Murley Score

研究概览

简要总结

Proximal humerus fractures (PHFs) are common osteoporotic fractures in adults and the elderly, leading to significant disability and reduced quality of life. Current treatment options for displaced PHFs include locking plate fixation (LCP) and various augmentation techniques, but there is no consensus on the optimal treatment. Although, femoral allografts have shown promising results, there is a need for more definitive evidence regarding the utilization of femoral graft augmentation in addition to locking plate fixation in 3- and 4-part PHFs. This study aims to evaluate the effectiveness of using a mushroom-shaped femoral allograft combined with LCP fixation compared to LCP fixation alone. We hypothesize that femoral allograft augmentation with LCP fixation will result in better clinical and functional outcomes than LCP fixation alone at 24 months post-operative

详细描述

Rationale: Proximal humerus fractures (PHFs) are common osteoporotic fractures in adults and the elderly, leading to significant disability and reduced quality of life. Current treatment options for displaced PHFs include locking plate fixation (LCP) and various augmentation techniques, but there is no consensus on the optimal treatment. Although, femoral allografts have shown promising results, there is a need for more definitive evidence regarding the utilization of femoral graft augmentation in addition to locking plate fixation in 3- and 4-part PHFs.

This study aims to evaluate the effectiveness of using a mushroom-shaped femoral allograft combined with LCP fixation compared to LCP fixation alone. We hypothesize that femoral allograft augmentation with LCP fixation will result in better clinical and functional outcomes than LCP fixation alone at 24 months post-operative.

Objective:

Primary Objective: To compare the CMS between patients treated with LCP fixation plus femoral allograft and those treated with LCP fixation alone at 24 months. The CMS is a validated tool used for assessing overall shoulder function, incorporating bothsubjective and objective components.

Secondary Objectives: To assess differences in clinical outcomes (using Oxford Shoulder Score, Subjective Shoulder Value, Numeric Rating Scale, EQ-5DL), radiological outcomes (humeral head height, humeral neck shaft angle), and the incidence of complications at 24 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between 40 and 70 years
  • Presenting with acute (< 3 weeks) 3- or 4-part PHF (NEER classification) Be able to understand and communicate in Dutch; Patient must be competent to make decisions; Patient is willing and able to complete scheduled study procedures Provide written IC.

排除标准

  • Head-split fractures;
  • Pathological fractures due to malignancy or metastases;
  • Individuals diagnosed with dementia or residing in institutional care or other cognitive impairment;
  • Terminal illness; Patients with convulsive disorders, collagen diseases, and any other condition that might affect the mobility of the shoulder joint; Active joint or systemic infection; History of prior surgery on the same shoulder; Previous fracture in the same shoulder; Psychiatric illness that precludes informed consent.

研究组 & 干预措施

Locking plate fixation alone

No Intervention

Locking plate fixation alone

Intervention

Experimental

Locking plate fixation with femoral allograft augmentation

干预措施: Locking plate fixation with femoral allograft augmentation (Procedure)

结局指标

主要结局

Constant Murley Score

时间窗: 24 months

Change in Constant Murley Score

次要结局

  • Oxford Shoulder Score(6 weeks, 6 months, 12 months and 24 months)
  • NRS(6 weeks, 6 months, 12 months and 24 months)
  • EQ-5D(6 weeks, 6 months, 12 months and 24 months)
  • SSV(6 weeks, 6 months, 12 months and 24 months)

研究者

发起方
Tergooi Medical Center
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验